文献速递甲状腺与颈部外科

早期复发的甲状腺乳头状癌是否只是持续性疾病?

Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease?
PubMed 文献 · Surgery · 2017-11-08

该回顾性研究分析了2000-2016年间因甲状腺乳头状癌再次手术的69例患者共92次手术,发现仅3次手术符合真正「复发」标准,71次为持续性疾病,42%的再次手术发生在术后1年内,中位首次再手术时间为21个月。

要点

  • 多数甲状腺乳头状癌再次手术针对的是持续性疾病而非真正复发。
  • 42%的再次手术发生在初次术后1年内,中位时间21个月。
  • 需改进术前评估和初次手术的彻底性以减少再次手术。

核心结论

  • 甲状腺乳头状癌的多数再次手术是针对持续性疾病,而非真正复发。

研究设计与样本

  • 回顾性分析前瞻性维护数据库,纳入2000-2016年因甲状腺乳头状癌疾病再次手术的患者69例,共92次手术。

主要发现

  • 初次病理平均肿瘤大小2.6 cm,51%多灶性,42%有甲状腺外侵犯。
  • 46%的患者初次手术时接受了中央/侧颈淋巴结清扫,77%接受了术后放射性碘治疗。
  • 首次再手术中位时间21个月(范围1-292),42%发生在1年内。
  • 仅3次手术符合真正「复发」标准,71次手术归类为持续性疾病。

关键数值与推荐

  • 复发定义为术后1年内甲状腺球蛋白检测不到且超声阴性后出现的疾病。

临床怎么用

  • 应优化术前评估和初次手术的彻底性,以降低持续性疾病导致的再次手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Papillary thyroid carcinoma has excellent survival, yet recurrence remains a challenge. We sought to determine the proportion of reoperations performed for persistent, rather than truly recurrent, disease. METHODS: We conducted a retrospective review of a prospectively maintained database. Patients with papillary thyroid carcinoma who underwent reoperation for disease from 2000-2016 were included. We defined recurrence as disease that developed after a patient had an undetectable thyroglobulin and a negative ultrasonography within 1 year of operation. RESULTS: A total of 69 patients underwent 92 reoperations. On initial pathology, mean tumor size was 2.6 cm, 51% were multifocal, and 42% had extrathyroidal extension. Half (46%) of the patients underwent a central/lateral neck dissection at the initial operation, and 77% were treated with postoperative radioactive iodine. The median time to first reoperation was 21 months (range, 1-292), and 42% occurred within 1 year. Only 3 operations met criteria for true "recurrence," while 71 operations were categorized as persistent disease. CONCLUSION: Many reoperations for papillary thyroid carcinoma are for management of persistent disease. More than half of the patients required reoperation within the first 2 years, which suggests strongly that improvements in the preoperative assessment and adequacy of initial operative therapy need to be made to improve the care of patients with thyroid cancer.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Bates MF, Lamas MR, Randle RW, et al. Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? Surgery. 2017. PMID: 29128176. doi:10.1016/j.surg.2017.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。